Akebia Financial Statements From 2010 to 2024

AKBA Stock  USD 1.88  0.06  3.30%   
Akebia Ther financial statements provide useful quarterly and yearly information to potential Akebia Ther investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Akebia Ther financial statements helps investors assess Akebia Ther's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Akebia Ther's valuation are summarized below:
Gross Profit
140 M
Profit Margin
(0.27)
Market Capitalization
397.1 M
Enterprise Value Revenue
2.4232
Revenue
169.9 M
We have found one hundred twenty available fundamental signals for Akebia Ther, which can be analyzed and compared to other ratios and to its rivals. All investors should make sure to validate all of Akebia Ther prevailing market performance against the performance between 2010 and 2024 to make sure the company can sustain itself down the road. The current year's Market Cap is expected to grow to about 443.8 M. The current year's Enterprise Value is expected to grow to about 394.5 M

Akebia Ther Total Revenue

189.1 Million

Check Akebia Ther financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Akebia Ther's main balance sheet or income statement drivers, such as Depreciation And Amortization of 39.5 M, Interest Expense of 9.4 M or Selling General Administrative of 3.1 M, as well as many indicators such as Price To Sales Ratio of 1.13, Dividend Yield of 0.0 or Days Sales Outstanding of 70.0. Akebia financial statements analysis is a perfect complement when working with Akebia Ther Valuation or Volatility modules.
  
Check out the analysis of Akebia Ther Correlation against competitors.
For information on how to trade Akebia Stock refer to our How to Trade Akebia Stock guide.

Akebia Ther Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Total Assets411.2 M241.7 M326.8 M
Slightly volatile
Other Current Liabilities67.9 M61.2 M54.5 M
Slightly volatile
Total Current Liabilities130.9 M99.9 M104.6 M
Slightly volatile
Accounts Payable18.7 M14.6 M14.9 M
Slightly volatile
Cash40.8 M42.9 M78.1 M
Slightly volatile
Cash And Short Term Investments40.8 M42.9 M128.3 M
Pretty Stable
Net Receivables28.3 M39.3 M23 M
Slightly volatile
Common Stock Shares Outstanding97.4 M187.5 M78.7 M
Slightly volatile
Liabilities And Stockholders Equity411.2 M241.7 M326.8 M
Slightly volatile
Other Current Assets12.6 M20.2 M10.1 M
Slightly volatile
Total Liabilities247.7 M272.3 M197.3 M
Slightly volatile
Total Current Assets112.2 M118.1 M185.5 M
Slightly volatile
Short and Long Term Debt Total72.1 M104.2 M45.1 M
Slightly volatile
Property Plant And Equipment Net18.1 M16 M13.3 M
Slightly volatile
Non Current Assets Total182 M123.6 M133.7 M
Slightly volatile
Non Currrent Assets Other20.8 M12.4 M15.5 M
Slightly volatile
Other Assets112.1 M108.7 M82.9 M
Slightly volatile
Non Current Liabilities Total127.4 M172.4 M93.4 M
Slightly volatile
Property Plant And Equipment Gross16.9 M16 M12.4 M
Slightly volatile
Short Term Debt20.8 M24 M14 M
Slightly volatile
Property Plant Equipment5.1 MM3.8 M
Slightly volatile
Other Liabilities95.8 M182 M70.8 M
Slightly volatile
Capital SurpluseB1.8 B789.4 M
Slightly volatile
Non Current Liabilities Other70.3 M62.9 M47.3 M
Slightly volatile
Net Invested Capital3.9 M4.1 M178.5 M
Very volatile
Net Working Capital17.4 M18.3 M154.1 M
Slightly volatile
Short and Long Term Debt32.4 M17.5 M34 M
Slightly volatile
Capital Stock1.5 K2.3 K1.2 K
Slightly volatile
Long Term Debt Total1.6 M1.6 M58.7 M
Slightly volatile
Capital Lease Obligations23.7 M13.4 M31 M
Slightly volatile

Akebia Ther Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization39.5 M37.6 M15 M
Slightly volatile
Interest Expense9.4 MM7.6 M
Slightly volatile
Selling General Administrative3.1 M3.2 M54.5 M
Slightly volatile
Other Operating Expenses300.1 M240.9 M239.4 M
Slightly volatile
Research Development59.9 M63.1 M111.7 M
Slightly volatile
Total Operating Expenses233.5 M201.1 M186.5 M
Slightly volatile
Preferred Stock And Other Adjustments69.5 M78.2 M85.2 M
Slightly volatile
Cost Of Revenue99.1 M74.1 M72.9 M
Slightly volatile
Interest Income865.3 K910.8 K1.3 M
Very volatile
Reconciled Depreciation29.6 M37.6 M14.8 M
Slightly volatile
Selling And Marketing Expenses89.1 M100.2 M96.9 M
Pretty Stable
Non Recurring12.7 M14.3 M15.6 M
Slightly volatile

Akebia Ther Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
Stock Based Compensation12.1 M9.3 M9.7 M
Slightly volatile
Begin Period Cash Flow101 M93.2 M80.9 M
Slightly volatile
Other Cashflows From Financing Activities950100026.8 M
Slightly volatile
End Period Cash Flow42.4 M44.6 M79.1 M
Slightly volatile
Depreciation43.9 M41.8 M15.8 M
Slightly volatile
Change To Netincome35.7 M53.7 M27 M
Slightly volatile

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio1.131.1944120
Slightly volatile
Days Sales Outstanding70.073.68533.8 K
Slightly volatile
Average Payables452.8 K509.4 K554.7 K
Slightly volatile
Stock Based Compensation To Revenue0.04550.04791.8056
Slightly volatile
Capex To Depreciation0.00330.00355.5354
Slightly volatile
EV To Sales1.431.509163.3536
Slightly volatile
Inventory Turnover2.54.72561.4562
Slightly volatile
Days Of Inventory On Hand73.3877.2393409
Very volatile
Payables Turnover4.815.06669.6444
Pretty Stable
Sales General And Administrative To Revenue0.530.567.0167
Slightly volatile
Average Inventory54 M51.4 M26.1 M
Slightly volatile
Research And Ddevelopement To Revenue0.310.324135.612
Slightly volatile
Capex To Revenue4.0E-44.0E-40.8119
Slightly volatile
Cash Per Share0.220.2292.4313
Pretty Stable
Days Payables Outstanding68.4472.0411K
Very volatile
Current Ratio1.121.1833.5347
Pretty Stable
Receivables Turnover5.354.95353.9447
Slightly volatile
Graham Number0.961.00837.5121
Pretty Stable
Capex Per Share7.0E-47.0E-40.0145
Very volatile
Average Receivables34.3 K38.5 K42 K
Slightly volatile
Revenue Per Share2.041.03821.1388
Slightly volatile
Interest Debt Per Share0.330.51620.2967
Slightly volatile
Debt To Assets0.390.37540.1124
Slightly volatile
Operating Cycle1431514.2 K
Slightly volatile
Days Of Payables Outstanding68.4472.0411K
Very volatile
Ebt Per Ebit0.821.12261.0059
Slightly volatile
Long Term Debt To Capitalization1.841.75310.4866
Slightly volatile
Total Debt To Capitalization1.581.50840.3485
Slightly volatile
Quick Ratio0.971.02593.405
Pretty Stable
Net Income Per E B T0.781.030.9668
Pretty Stable
Cash Ratio0.410.42981.4661
Slightly volatile
Days Of Inventory Outstanding73.3877.2393409
Very volatile
Days Of Sales Outstanding70.073.68533.8 K
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio0.80.90.9835
Slightly volatile
Fixed Asset Turnover16.2812.12989.2143
Slightly volatile
Debt Ratio0.390.37540.1124
Slightly volatile
Price Sales Ratio1.131.1944120
Slightly volatile
Asset Turnover0.850.80520.3013
Slightly volatile

Akebia Ther Valuation Data

Current ValueLast YearHistorical Average 10 Year Trend
Market Cap443.8 M232.5 M388.4 M
Pretty Stable
Enterprise Value394.5 M293.7 M349.1 M
Pretty Stable

Akebia Fundamental Market Drivers

Cash And Short Term Investments42.9 M

Akebia Upcoming Events

14th of March 2024
Upcoming Quarterly Report
View
13th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
14th of March 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About Akebia Ther Financial Statements

Akebia Ther stakeholders use historical fundamental indicators, such as Akebia Ther's revenue or net income, to determine how well the company is positioned to perform in the future. Although Akebia Ther investors may analyze each financial statement separately, they are all interrelated. For example, changes in Akebia Ther's assets and liabilities are reflected in the revenues and expenses on Akebia Ther's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Akebia Ther. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Current Deferred Revenue22.9 M29 M
Total Revenue194.6 M189.1 M
Cost Of Revenue74.1 M99.1 M
Stock Based Compensation To Revenue 0.05  0.05 
Sales General And Administrative To Revenue 0.56  0.53 
Research And Ddevelopement To Revenue 0.32  0.31 
Revenue Per Share 1.04  2.04 
Ebit Per Revenue(0.24)(0.25)

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Akebia Ther offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Akebia Ther's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Akebia Ther Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Akebia Ther Stock:
Check out the analysis of Akebia Ther Correlation against competitors.
For information on how to trade Akebia Stock refer to our How to Trade Akebia Stock guide.
You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Akebia Ther. If investors know Akebia will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Akebia Ther listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.22)
Revenue Per Share
0.834
Quarterly Revenue Growth
(0.11)
Return On Assets
(0.09)
Return On Equity
(5.53)
The market value of Akebia Ther is measured differently than its book value, which is the value of Akebia that is recorded on the company's balance sheet. Investors also form their own opinion of Akebia Ther's value that differs from its market value or its book value, called intrinsic value, which is Akebia Ther's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Akebia Ther's market value can be influenced by many factors that don't directly affect Akebia Ther's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Akebia Ther's value and its price as these two are different measures arrived at by different means. Investors typically determine if Akebia Ther is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Akebia Ther's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.